Cargando…
Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical
The prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR) are identified as important targets on prostate cancer. Receptor-targeting radiolabeled imaging pharmaceuticals with high affinity and specificity are useful in studying and monitoring biological processes an...
Autores principales: | Ghosh, Arijit, Woolum, Karen, Kothandaraman, Shankaran, Tweedle, Michael F., Kumar, Krishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720803/ https://www.ncbi.nlm.nih.gov/pubmed/31398865 http://dx.doi.org/10.3390/molecules24162878 |
Ejemplares similares
-
The Gastrin-Releasing Peptide Receptor (GRPR) in the Spinal Cord as a Novel Pharmacological Target
por: Takanami, Keiko, et al.
Publicado: (2014) -
How gastrin-releasing peptide receptor (GRPR) and α(v)β(3) integrin expression reflect reorganization features of tumors after hyperthermia treatments
por: Hallasch, Sandra, et al.
Publicado: (2017) -
Preclinical Characterization of a Stabilized Gastrin-Releasing Peptide Receptor Antagonist for Targeted Cancer Theranostics
por: Abouzayed, Ayman, et al.
Publicado: (2023) -
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies
por: Chatalic, Kristell L.S., et al.
Publicado: (2016) -
Novel Peptide NIRF Optical Surgical Navigation Agents for HNSCC
por: Ding, Haiming, et al.
Publicado: (2019)